Treatment.com International Inc. (“Treatment or the “Company”) (CSE: TRUE) (OTC: TREIF) (FSE: 939), a healthcare AI technology company is pleased to announce that the Company’s common shares traded on the OTC Markets Group Inc.’s OTCQB Venture Market in the United States, under the symbol “TREIF”, are now Depository Trust Company (“DTC”) eligible. DTC is a subsidiary of the Depository Trust & Clearing Corporation and manages the electronic clearing and settlement of share transactions for publicly traded companies.
The OTCQB Venture Market is for early-stage and developing U.S. and international companies that must be current in their reporting and undergo an annual verification and management certification process. DTC eligibility allows Treatment shares to be more easily and economically transferred between brokerage accounts electronically within the United States. DTC is the largest securities depository in the world, providing clearing and settlement efficiencies for brokers, as well as various other services.
In addition to the OTCQB, shares of Treatment will continue to trade on the Canadian Securities Exchange under symbol “TRUE”.